Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip

  • Technology appraisal guidance
  • TA304
  • Published: 
Download guidance (PDF)

10 Sources of evidence considered by the Committee

A. The assessment report for this appraisal was prepared by Warwick Evidence:

  • Clarke A, Pulikottil-Jacob R, Grove A. et al. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end stage arthritis of the hip (Review of technology appraisal guidance 2 and 44), July 2013

B. The following organisations accepted the invitation to participate in this appraisal as consultees and commentators. They were invited to comment on the draft scope, assessment report and the appraisal consultation document (ACD). Organisations listed in I, II and III were also invited to make written submissions and have the opportunity to appeal against the final appraisal determination.

I. Manufacturers/sponsors:

  • B Braun

  • Biomet

  • DePuy-Synthes (Johnson & Johnson)

  • JRI

  • Smith & Nephew

  • Stryker

  • Wright Medical

  • Zimmer

II. Professional/specialist and patient/carer groups:

  • Arthritis Care

  • Association for Perioperative Practice

  • British Hip Society

  • British Orthopaedic Association

  • Chartered Society of Physiotherapy

  • Primary Care Rheumatology Society

  • Royal College of Nursing

  • Royal College of Physicians

III. Other consultees:

  • Department of Health

  • Welsh Government

IV. Commentator organisations (without the right of appeal):

  • Association of British Healthcare Industries (ABHI)

  • Commissioning Support Appraisals Service

  • Department of Health, Social Services and Public Safety for Northern Ireland

  • EUCOMED

  • Healthcare Improvement Scotland

  • Medicines and Healthcare products Regulatory Agency

  • NHS Confederation

  • NHS Supply Chain

  • Orthopaedic Research UK

C. The following individual was selected from clinical specialist and patient expert nominations from the consultees and commentators. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on total hip replacement and resurfacing arthroplasty by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the ACD.

  • Mary Drozd, Senior Lecturer, University of Wolverhampton, nominated by the Royal College of Nursing – clinical specialist

E. Representatives from the following manufacturers/sponsors attended Committee meetings. They contributed only when asked by the Committee chair to clarify specific issues and comment on factual accuracy.

  • Johnson & Johnson

  • JRI

  • Smith and Nephew

  • Stryker